D1 and D2 dopamine receptors are expressed in disjoint subsets of striatal projection neurons, the direct and indirect pathways, respectively. This differential distribution of receptors forms the basis for explanations of many aspects of basal ganglia function and dysfunction, but it seems incompatible with some other important properties of striatal neurons. In this issue of Neuron, Wang et al. discover the mechanism of D2 sensitivity of long term depression at synapses on the striatal projection neuron. They show that D2 dependence of LTD does not depend on dopamine receptors of on the projection cell but is mediated by dopamine-induced changes in release of acetylcholine by interneurons that contact projection cells of both types.
The differential roles of D1 and D2 dopamine receptors have been a recurring theme in the study of the basal ganglia neurophysiology and behavioral pharmacology. At the core of most models of the pathophysiology of Parkinson's disease lies the idea that D1 and D2 receptors differentially affect the two groups of striatal principal neurons, the cells of the direct and indirect pathways. One premise of these models, that D1 receptors are expressed by approximately one half of all striatal projection neurons and D2 receptors by the other, has been established by studies of RNA content and protein expression (Gerfen, 1992; Surmeier et al., 1996) . This general arrangement is shown in Figure 1 . Cells of both types are GABAergic and have very similar appearance and firing patterns. But the ones that express the D1 receptor also express substance P as a cotransmitter, and their axons innervate both segments of the globus pallidus and substantia nigra. These cells, the direct pathway cells, make monosynaptic connections to the basal ganglia output neurons in the internal globus pallidus segment and substantia nigra, pars reticulata. The D2-expressing striatal projection neurons contain dynorphin and enkephalin, and their axons project only as far as the external segment of the globus pallidus, where they can contact no basal ganglia output cells. The differential control of these two pathways by dopamine forms the basis for the explanation of a large body of empirical data on these structures and their relationship to behavior.
On the other hand, there has long been another thread of research insisting that D1 and D2 receptors are colocalized on spiny cells. Studies of dopaminergic modulation of ion channels, firing properties, and synaptic transmission have shown that individual spiny neurons respond to both D1 and D2 agonists (e.g., Aizman et al. [2000] ; Surmeier et al. [1993] ). It has been difficult to reconcile these two lines of thought, each of which is supported by a large body of experimental data. One of the clearest phenomena that appears to require coexistence of dopamine receptors on spiny neurons is long-term depression (LTD) of glutamatergic afferent synapses on the spiny neuron. It has been shown that high-frequency stimulation of glutamatergic afferents will evoke LTD in effectively all striatal projection neurons. The tricky part is that LTD has been shown to require activation of D2 receptors. How can LTD depend on D2 receptor activation in spiny projection neurons that don't express the D2 receptor? Similar results abound. NMDA receptordependent LTP is also seen in most or all spiny projection neurons but is blocked by antagonists of D1 receptors (Kerr and Wickens, 2001; Centonze et al., 2003) . D1 and D2 receptor agonists alter excitability in all spiny neurons (Onn et al., 2003; Ding and Perkel, 2002) , and there are many studies showing nonadditive effects of D1 and D2 receptor on biochemical and behavioral measures (e.g., Keefe and Gerfen [1995] ). Faced with these results, some have insisted that the results showing differential distribution of D1 and D2 receptors in the striatum must simply be wrong. One source of doubt about these experiments concerns identification of neurons. The arguments about cell identity have been indirect, being based on the assumption of equal sampling of direct and indirect pathway spiny neurons. In a more perfect world, we would determine the identity of every single cell at the time of the experiment and show for sure whether direct pathway neurons could respond to D2 receptor agonists.
Showing that spiny projection cells lacking the D2 receptor respond to D2 agonists within the circuitry of the striatum isn't all that startling. Spiny cells predominate in the striatum, but there are plenty of other cell types. The distribution of dopamine receptors has not been determined for all the interneurons, but at least one kind of interneuron has been shown to have both receptor types. The cholinergic interneuron, representing only about 1/ 100 of the cells in the striatum, has long been known to be responsive to dopamine. Investigators studying dopamine regulation of acetylcholine turnover in the 1970's concluded that the influence of dopamine in the striatum was primarily exerted on the cholinergic interneuron, which relayed its effects to the spiny cells. This line of work, refined over 30 years, shows that acetylcholine release in the striatum is tightly regulated by dopamine via both D1 and D2 receptor types (DeBoer and Abercrombie, 1996) . But the idea of primary mediation of dopamine effects by acetylcholine lost its purchase when dopamine receptors were discovered on the spiny cells. The most parsimonious explanation was that dopaminergic control of spiny cells was direct.
In this issue of Neuron, Wang and colleagues (2006) look directly at the D2-receptor sensitivity of LTD in spiny neurons. They use BAC transgenic mice with fluorescent reporters driven by the D1-or D2-receptor promoters to identify cells at the time of the experiment and show that D2-receptor-dependent LTD occurs as readily in both the direct and indirect pathway spiny cells. In a sequence of pharmacological experiments they reveal the participation of at least five intervening steps between the D2 receptor and LTD of glutamatergic synapses on the spiny neuron. The cholinergic neurons play the key role of intermediate between dopamine and the spiny neuron, and the spiny neuron D2 receptor appears nowhere in the explanation. D2 receptors on the cholinergic cell act to inhibit the release of acetylcholine, which reduces the m1-mediated inhibitory modulation of L-type calcium channels, resulting in increased calcium entry and calcium-dependent release of cannabanoids from the postsynaptic spiny neuron, which then acts presynaptically to reduce the release of glutamate. The mechanism as they show it explains a number of well-known features of striatal LTD, including its dependence on L-type calcium channels and metabotropic glutamate receptors. It is complicated, however. It is so complicated that if it had been proposed in the absence of so clear an experimental demonstration of its truth, it would probably have been rejected as unparsimonious. One lesson if this work is that parsimony is often not a reliable basis of judgment. We have clearly been using Occam's Razor incorrectly, and maybe it would be best if we just left it alone for a while.
One implication of these findings concerns the spatial range of dopamine's effects. When dopamine was thought to act directly on spiny neurons, one could imagine its effects being localized to limited parts of the spiny cell, or even particular synapses. In the authors' diagram in Figure 7 , the critical parts of the signaling pathway controlling release of endocannabanoids, including the m1 receptor, are shown as contained within a dendritic spine. This localization of everything in each spine is not meant to be taken too literally. Cholinergic interneurons are few and their dendritic and axonal arborizations are widespread. The effects of dopamine relayed through cholinergic cells probably occur on a spatial scale larger than a single synapse, or even a single spiny cell. Synaptic specificity for LTD must be mediated by the glutamatergic side of the mechanism, either in the local activation of voltage-gated calcium channels in the spine (e.g., Carter and Sabatini [2004] ), in the mGluR activation that can trigger release of calcium from intracellular stores, or both.
These findings forecast a comeback for the cholinergic cell as an intermediary between dopaminergic inputs
